Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H26N4O4 |
Molecular Weight | 386.4448 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(CNCCC2CCOCC2)=CC=C1OC3=CN=C(C=N3)C(N)=O
InChI
InChIKey=ZGCYVRNZWGUXNQ-UHFFFAOYSA-N
InChI=1S/C20H26N4O4/c1-26-18-10-15(11-22-7-4-14-5-8-27-9-6-14)2-3-17(18)28-19-13-23-16(12-24-19)20(21)25/h2-3,10,12-14,22H,4-9,11H2,1H3,(H2,21,25)
Molecular Formula | C20H26N4O4 |
Molecular Weight | 386.4448 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL233 Sources: https://clinicaltrials.gov/ct2/show/NCT01275755 |
|||
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01901341
0.25 milligrams (mg) CB-5945 (bevenopran) administered orally twice daily (BID) for a 12-week treatment period
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 02:15:44 GMT 2023
by
admin
on
Sat Dec 16 02:15:44 GMT 2023
|
Record UNII |
IC58Q2EHPJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID90217963
Created by
admin on Sat Dec 16 02:15:44 GMT 2023 , Edited by admin on Sat Dec 16 02:15:44 GMT 2023
|
PRIMARY | |||
|
C169810
Created by
admin on Sat Dec 16 02:15:44 GMT 2023 , Edited by admin on Sat Dec 16 02:15:44 GMT 2023
|
PRIMARY | |||
|
9595
Created by
admin on Sat Dec 16 02:15:44 GMT 2023 , Edited by admin on Sat Dec 16 02:15:44 GMT 2023
|
PRIMARY | |||
|
IC58Q2EHPJ
Created by
admin on Sat Dec 16 02:15:44 GMT 2023 , Edited by admin on Sat Dec 16 02:15:44 GMT 2023
|
PRIMARY | |||
|
300000034082
Created by
admin on Sat Dec 16 02:15:44 GMT 2023 , Edited by admin on Sat Dec 16 02:15:44 GMT 2023
|
PRIMARY | |||
|
10452732
Created by
admin on Sat Dec 16 02:15:44 GMT 2023 , Edited by admin on Sat Dec 16 02:15:44 GMT 2023
|
PRIMARY | |||
|
Bevenopran
Created by
admin on Sat Dec 16 02:15:44 GMT 2023 , Edited by admin on Sat Dec 16 02:15:44 GMT 2023
|
PRIMARY | |||
|
YY-154
Created by
admin on Sat Dec 16 02:15:44 GMT 2023 , Edited by admin on Sat Dec 16 02:15:44 GMT 2023
|
PRIMARY | |||
|
CHEMBL3039511
Created by
admin on Sat Dec 16 02:15:44 GMT 2023 , Edited by admin on Sat Dec 16 02:15:44 GMT 2023
|
PRIMARY | |||
|
DB12464
Created by
admin on Sat Dec 16 02:15:44 GMT 2023 , Edited by admin on Sat Dec 16 02:15:44 GMT 2023
|
PRIMARY | |||
|
676500-67-7
Created by
admin on Sat Dec 16 02:15:44 GMT 2023 , Edited by admin on Sat Dec 16 02:15:44 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|